Challenges of intracellular visualization using virtual and augmented reality.
augmented reality
bioimaging
intracellular imaging
multi-dimensional biological data
virtual reality
Journal
Frontiers in bioinformatics
ISSN: 2673-7647
Titre abrégé: Front Bioinform
Pays: Switzerland
ID NLM: 9918227263306676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
07
2022
accepted:
26
08
2022
entrez:
28
10
2022
pubmed:
29
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Microscopy image observation is commonly performed on 2D screens, which limits human capacities to grasp volumetric, complex, and discrete biological dynamics. With the massive production of multidimensional images (3D + time, multi-channels) and derived images (e.g., restored images, segmentation maps, and object tracks), scientists need appropriate visualization and navigation methods to better apprehend the amount of information in their content. New modes of visualization have emerged, including virtual reality (VR)/augmented reality (AR) approaches which should allow more accurate analysis and exploration of large time series of volumetric images, such as those produced by the latest 3D + time fluorescence microscopy. They include integrated algorithms that allow researchers to interactively explore complex spatiotemporal objects at the scale of single cells or multicellular systems, almost in a real time manner. In practice, however, immersion of the user within 3D + time microscopy data represents both a paradigm shift in human-image interaction and an acculturation challenge, for the concerned community. To promote a broader adoption of these approaches by biologists, further dialogue is needed between the bioimaging community and the VR&AR developers.
Identifiants
pubmed: 36304296
doi: 10.3389/fbinf.2022.997082
pii: 997082
pmc: PMC9580941
doi:
Banques de données
figshare
['10.6084/m9.figshare.20290155']
Types de publication
Journal Article
Langues
eng
Pagination
997082Informations de copyright
Copyright © 2022 Valades-Cruz, Leconte, Fouche, Blanc, Van Hille, Fournier, Laurent, Gallean, Deslandes, Hajj, Faure, Argelaguet, Trubuil, Isenberg, Masson, Salamero and Kervrann.
Déclaration de conflit d'intérêts
J-BM is one of the cofounders, shareholder and Chief Scientific Officer (CSO) of AVATAR MEDICAL SAS, a startup that commercializes software for surgery planning in virtual reality. The DIVA software used in this perspective is not being commercialized by AVATAR MEDICAL SAS although the company’s technology is based on the same technology. The DIVA software used here is freely available and is reported in El Beheiry, et al. “DIVA: Natural Navigation Inside 3D Images Using Virtual Reality”. Journal of Molecular Biology 432, no. 16 (2020): 474. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Methods. 2020 Nov;17(11):1100-1102
pubmed: 32958921
IEEE Trans Vis Comput Graph. 2017 Sep;23(9):2151-2164
pubmed: 28113509
Science. 2014 Oct 24;346(6208):1257998
pubmed: 25342811
IEEE Trans Vis Comput Graph. 2021 Mar;27(3):2101-2122
pubmed: 31352344
BMC Bioinformatics. 2019 Feb 15;20(1):78
pubmed: 30767777
IEEE Trans Vis Comput Graph. 2022 Jun;28(6):2530-2549
pubmed: 33085619
Dev Cell. 2013 Aug 12;26(3):279-91
pubmed: 23891661
Nat Methods. 2012 Jun 28;9(7):690-6
pubmed: 22743774
J Mol Biol. 2018 Oct 19;430(21):4028-4035
pubmed: 29949752
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
J Mol Biol. 2020 Jul 24;432(16):4745-4749
pubmed: 32512003
Nat Methods. 2020 Nov;17(11):1097-1099
pubmed: 33046895
Nat Methods. 2017 Aug;14(8):775-781
pubmed: 28775673
Nat Commun. 2019 Jun 27;10(1):2812
pubmed: 31249294
Nat Methods. 2015 Jun;12(6):480-1
pubmed: 26020498
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30055-30062
pubmed: 32471948
J Mol Graph Model. 2022 Jul;114:108164
pubmed: 35325844
Nat Methods. 2022 Jul;19(7):829-832
pubmed: 35654950